Brief: Omega Therapeutics Reports Third Quarter 2023 Financial Results And Highlights Recent Company Progress
09/11/2023 12:38
Nov 9 (Reuters) - Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT COMPANY PROGRESS
* AS OF SEPTEMBER 30, 2023, COMPANY HAD CASH, CASH
EQUIVALENTS AND
MARKETABLE SECURITIES TOTALING $89.3 MILLION
* QTRLY NET LOSS PER COMMON STOCK ATTRIBUTABLE TO COMMON
STOCKHOLDERS, BASIC AND DILUTED$0.40
* Q3 EARNINGS PER SHARE VIEW $-0.53 -- LSEG IBES DATA
* FURTHER STRENGTHENED BOARD OF DIRECTORS WITH APPOINTMENT
OF
CHRIS SCHADE AS CHAIRMAN AND ADDITION OF MICHELLE C. WERNER
Source text for Eikon: ID:nGNX4NrhR3
Further company coverage: OMGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence